Correlation Between Regeneron Pharmaceuticals and Reunion Neuroscience

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Reunion Neuroscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Reunion Neuroscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and Reunion Neuroscience, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Reunion Neuroscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Reunion Neuroscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Reunion Neuroscience.

Diversification Opportunities for Regeneron Pharmaceuticals and Reunion Neuroscience

0.0

Correlation Coefficient

Regeneron Pharmaceuticals  Reunion Neuroscience

Pay attention - limited upside

The 3 months correlation between Regeneron and Reunion is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Reunion Neuroscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reunion Neuroscience and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Reunion Neuroscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reunion Neuroscience has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Reunion Neuroscience go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Reunion Neuroscience

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 6.19 times less return on investment than Reunion Neuroscience. But when comparing it to its historical volatility, Regeneron Pharmaceuticals is 4.87 times less risky than Reunion Neuroscience. It trades about 0.01 of its potential returns per unit of risk. Reunion Neuroscience is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  132.00  in Reunion Neuroscience on October 12, 2024 and sell it today you would lose (20.00) from holding Reunion Neuroscience or give up 15.15% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	25.66%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  Reunion Neuroscience

Regeneron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Reunion Neuroscience

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Reunion Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Reunion Neuroscience is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Regeneron Pharmaceuticals and Reunion Neuroscience

The main advantage of trading using opposite Regeneron Pharmaceuticals and Reunion Neuroscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Reunion Neuroscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will offset losses from the drop in Reunion Neuroscience's long position.

The idea behind Regeneron Pharmaceuticals and Reunion Neuroscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.